Mutual of America Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-276,044
| Closed | -$3.93M | – | 1381 |
|
|
2025
Q4 | $3.93M | Sell |
276,044
-1,672
| -0.6% | -$16.4K | 0.04% | 516 |
|
|
2025
Q3 | $2.19M | Buy |
277,716
+6,016
| +2% | +$42.8K | 0.02% | 786 |
|
|
2025
Q2 | $1.56M | Buy |
271,700
+23,091
| +9% | +$149K | 0.02% | 888 |
|
|
2025
Q1 | $2.03M | Buy |
248,609
+859
| +0.3% | +$7.95K | 0.02% | 829 |
|
|
2024
Q4 | $2.33M | Sell |
247,750
-218
| -0.1% | -$2.27K | 0.03% | 803 |
|
|
2024
Q3 | $2.65M | Sell |
247,968
-2,325
| -0.9% | -$25.3K | 0.03% | 778 |
|
|
2024
Q2 | $2.48M | Buy |
250,293
+48,802
| +24% | +$501K | 0.03% | 784 |
|
|
2024
Q1 | $2.37M | Sell |
201,491
-16,368
| -8% | -$209K | 0.03% | 829 |
|
|
2023
Q4 | $3.09M | Buy |
217,859
+46,762
| +27% | +$531K | 0.04% | 697 |
|
|
2023
Q3 | $2.08M | Sell |
171,097
-10,189
| -6% | -$131K | 0.03% | 852 |
|
|
2023
Q2 | $2.28M | Sell |
181,286
-13,855
| -7% | -$164K | 0.03% | 847 |
|
|
2023
Q1 | $2.16M | Sell |
195,141
-8,996
| -4% | -$111K | 0.03% | 868 |
|
|
2022
Q4 | $2.49M | Buy |
204,137
+2,739
| +1% | +$30.8K | 0.03% | 806 |
|
|
2022
Q3 | $2.1M | Buy |
201,398
+16,623
| +9% | +$185K | 0.03% | 830 |
|
|
2022
Q2 | $1.98M | Sell |
184,775
-1,389
| -0.7% | -$11.4K | 0.03% | 875 |
|
|
2022
Q1 | $1.76M | Sell |
186,164
-8,100
| -4% | -$76K | 0.02% | 982 |
|
|
2021
Q4 | $2.24M | Sell |
194,264
-1,817
| -0.9% | -$20.3K | 0.02% | 936 |
|
|
2021
Q3 | $1.87M | Sell |
196,081
-2,831
| -1% | -$29K | 0.02% | 972 |
|
|
2021
Q2 | $1.92M | Sell |
198,912
-8,552
| -4% | -$83.5K | 0.02% | 984 |
|
|
2021
Q1 | $2.05M | Sell |
207,464
-11,453
| -5% | -$177K | 0.02% | 956 |
|
|
2020
Q4 | $5.05M | Buy |
218,917
+15,508
| +8% | +$317K | 0.06% | 446 |
|
|
2020
Q3 | $2.87M | Sell |
203,409
-34,845
| -15% | -$508K | 0.04% | 642 |
|
|
2020
Q2 | $3.59M | Buy |
238,254
+39,188
| +20% | +$478K | 0.05% | 517 |
|
|
2020
Q1 | $1.84M | Sell |
199,066
-8,765
| -4% | -$83.3K | 0.03% | 744 |
|
|
2019
Q4 | $2.02M | Sell |
207,831
-1,410
| -0.7% | -$12.9K | 0.03% | 901 |
|
|
2019
Q3 | $1.68M | Sell |
209,241
-1,165
| -0.6% | -$12.6K | 0.02% | 930 |
|
|
2019
Q2 | $2.63M | Buy |
210,406
+138
| +0.1% | +$1.75K | 0.04% | 752 |
|
|
2019
Q1 | $2.86M | Buy |
210,268
+3,819
| +2% | +$46.7K | 0.04% | 686 |
|
|
2018
Q4 | $1.98M | Hold |
206,449
| – | – | 0.03% | 807 |
|
|
2018
Q3 | $2.5M | Sell |
206,449
-1,511
| -0.7% | -$21.1K | 0.04% | 800 |
|
|
2018
Q2 | $3.25M | Hold |
207,960
| – | – | 0.05% | 650 |
|
|
2018
Q1 | $3.13M | Hold |
207,960
| – | – | 0.05% | 633 |
|
|
2017
Q4 | $2.99M | Buy |
207,960
+129,560
| +165% | +$1.78M | 0.05% | 673 |
|
|
2017
Q3 | $1.18M | Buy |
+78,400
| New | +$1.04M | 0.02% | 1035 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Mutual of America Capital Management's FOLD Position: Q1 2026 in Review
Mutual of America Capital Management sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 276,044 shares — an estimated $3.93M sold.
Mutual of America Capital Management first reported a position in FOLD in Q3 2017 and held it in 34 quarters. The position peaked at $5.05M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Mutual of America Capital Management reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
- Mutual of America Capital Management sold 276,044 Amicus Therapeutics shares in Q1 2026, an estimated $3.93M.
- Mutual of America Capital Management first reported a position in Amicus Therapeutics in Q3 2017 and held it in 34 quarters.
- Mutual of America Capital Management's Amicus Therapeutics position peaked at $5.05M in Q4 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.